- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05987566
Chronobiology of Meal Timing: Effects on Vascular and Renal Function
March 15, 2024 updated by: Virginia Commonwealth University
The purpose of this study us to investigate the effects of mistimed eating on blood pressure, kidney function and vascular function.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Despite advancements in pharmacologic antihypertensives, hypertension currently affects 1 in 3 Americans and accounts for more than $50 billion of health care spending.
Importantly, hypertension is the leading cause of cardiovascular (CVD) and kidney diseases (CKD).
As a result, the AHA/ACC lowered the diagnostic criteria for hypertension to encourage earlier preventative lifestyle intervention.
There is a critical need to identify and implement novel lifestyle interventions in individuals with early-stage hypertension to prevent the subsequent development of CVD and CKD.
Chronotherapy that aligns behavioral cues (such as time of eating) with the body's internal biological clocks, has gained much attention as a potential strategy to prevent and manage hypertension, however, the underlying mechanisms are not yet fully understood.
The purpose of this study is to investigate the effects of mistimed eating on blood pressure, kidney function and vascular function.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Natalie Bohmke
- Phone Number: (540) 842-9009
- Email: bohmkenj@vcu.edu
Study Contact Backup
- Name: Danielle Kirkman
- Phone Number: dlkirkman@vcu.edu
- Email: dlkirkman@vcu.edu
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 232398
- Virginia Commonwealth Univesity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Men and Women aged 18-45 years
- Elevated (SBP 120-129; DBP <80 mmHg) or stage 1 hypertension (SBP 130-139; DBP 80-89 mmHg)
Exclusion Criteria:
- History of chronic disease (CV, lung, cancer, renal, sleep apnea, diabetes, autoimmune)
- Anti-hypertensive medication use
- Currently pregnant or lactating
- Current shift worker
- Travel >3 time zones four weeks before the start of the study or during the study
- Insomnia
- Practiced intermittent fasting in past six months
- Current nicotine use
- Current hormone replacement therapy
- Current melatonin use
- Current use of antioxidants and unwilling to stop taking them for the duration of the study
- Unable to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Morning Meal Challenge
|
A Western-style diet meal which will be individualized for caloric consumption by estimated total daily energy expenditure eaten after 1 hour of waking up in the morning
|
Experimental: Late Night Meal Challenge
|
A Western-style diet meal which will be individualized for caloric consumption by estimated total daily energy expenditure eaten within 1 hour of going to bed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urinary sodium excretion and markers of kidney injury
Time Frame: 24 hours
|
Day and nocturnal urinary sodium, NGAL and KIM-1
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24hr ambulatory blood pressure
Time Frame: 24 Hours
|
Day and nocturnal ambulatory blood pressure
|
24 Hours
|
Macrovascular function
Time Frame: At baseline and after each 24hour experimental arm
|
Brachial artery endothelial function assessed by flow mediated dilation
|
At baseline and after each 24hour experimental arm
|
Microvascular function
Time Frame: At baseline and after each 24hour experimental arm
|
Skin blood flow response to local heating measured by laser doppler flowmetry
|
At baseline and after each 24hour experimental arm
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Danielle Kirkman, Virginia Commonwealth University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2023
Primary Completion (Actual)
March 6, 2024
Study Completion (Actual)
March 6, 2024
Study Registration Dates
First Submitted
July 31, 2023
First Submitted That Met QC Criteria
August 4, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 15, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20026660
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
Clinical Trials on Morning meal challenge
-
Aarhus University HospitalDiabetesforeningenUnknown
-
North Dakota State UniversityCompleted
-
Charite University, Berlin, GermanyCompleted
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
King's College LondonCompleted
-
USDA, Western Human Nutrition Research CenterRecruiting
-
Menzies Institute for Medical ResearchDeakin UniversityActive, not recruiting
-
Emory UniversityTerminated
-
Wageningen University and ResearchCompletedGlucose Metabolism | Lipid MetabolismNetherlands
-
University of California, DavisUSDA, Western Human Nutrition Research CenterRecruiting